Skip to main content
HL CORP (SHENZHEN) logo

HL CORP (SHENZHEN) — Investor Relations & Filings

Ticker · 002105 ISIN · CNE000001Q77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,593 across all filing types
Latest filing 2023-03-16 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002105

About HL CORP (SHENZHEN)

https://www.hlcorp.com

HL CORP (SHENZHEN) specializes in the research, development, and manufacturing of bicycle components and fitness equipment. The company is widely recognized for its 'ZOOM' brand, producing a comprehensive range of products including handlebars, stems, seat posts, suspension forks, and braking systems. Its portfolio also encompasses specialized components for electric bicycles and rehabilitation equipment. Serving as a major supplier for the global cycling market, the firm provides original equipment manufacturer (OEM) and original design manufacturer (ODM) services to numerous international brands. HL CORP (SHENZHEN) focuses on technical innovation, precision engineering, and large-scale production capabilities to meet diverse performance and safety requirements. The company integrates advanced materials and ergonomic designs to enhance product durability and user experience across various cycling disciplines.

Recent filings

Filing Released Lang Actions
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the third meeting of the seventh board of directors of Shenzhen Xinlong Health Industry Development Co., Ltd. It includes multiple agenda items such as approval of the 2022 annual general manager work report, board work report, financial statements, profit distribution plan, internal control self-assessment report, remuneration for directors and senior management, accounting policy changes, appointment of auditors, audit fees, and bank credit line applications. The document contains voting results and decisions made by the board, and references the upcoming submission of these items to the shareholders' meeting for approval. It also mentions that the full 2022 annual report and related documents are published separately on the designated information disclosure media. The document is not the annual report itself but a board meeting resolution announcement covering multiple governance and management topics, including financial and audit matters, and capital/financing updates (bank credit lines). Given the comprehensive nature of the board meeting resolutions and the focus on board decisions, this document best fits the category of Board/Management Information (MANG). It is not a full annual report (10-K), nor a simple announcement of a report publication (RPA), nor a capital/financing update (CAP) alone, but a board meeting resolutions announcement covering multiple governance and management topics.
2023-03-16 Chinese
独立董事对担保等事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion report related to the company's seventh board meeting. It includes detailed independent opinions on various matters such as related party transactions, external guarantees, profit distribution plan for 2022, internal control self-evaluation report, remuneration of directors and senior management, accounting policy changes, and the 2022 annual report. It also mentions the appointment of the auditing firm for 2023. The document references the 2022 annual report and audit but does not contain the full annual report or financial statements itself. Instead, it provides independent directors' opinions on these matters, which is typical for a Board/Management Information filing. The document is not a full Annual Report (10-K), nor is it a simple announcement or certification. It is a detailed management/board related document expressing independent opinions on key corporate governance and financial matters discussed at a board meeting.
2023-03-16 Chinese
独立董事对第七届董事会第三次会议相关事项的事前认可意见
Audit Report / Information Classification · 90% confidence The document is a statement from independent directors providing their prior approval opinion regarding the appointment of an audit firm for the company's 2023 financial and internal control audit. It references regulatory rules and company bylaws but does not contain actual financial statements or audit results. The document length is short (485 characters) and it is essentially an approval or opinion related to audit matters, not the audit report itself. Therefore, it is best classified as an Audit Report / Information (AR) since it relates to audit matters but is not a full annual report or audit report itself. Confidence is high due to clear context and content. FY 2023
2023-03-16 Chinese
关于2022年度利润分配预案的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the 2022 profit distribution plan of Shenzhen Xinlong Health Industry Development Co., Ltd. It includes details about the proposed dividend payout, retained earnings, and legal reserve allocations. The announcement states that the profit distribution plan needs to be approved at the 2022 annual shareholders' meeting. It contains no full financial statements or comprehensive financial performance data, but rather a proposal and related approvals from the board, supervisory committee, and independent directors. The document is short (1551 characters) and serves as a formal notice of the profit distribution plan rather than a full annual report or interim report. Therefore, it fits best under the category of Notice of Dividend Amount (DIV), which covers announcements of dividend amounts, payment dates, and related shareholder information.
2023-03-16 Chinese
2022年度监事会工作报告
Audit Report / Information Classification · 95% confidence The document is titled as the "2022 Annual Supervisory Board Work Report" of Shenzhen Xinlong Health Industry Development Co., Ltd. It details the supervisory board's activities, meetings, oversight of financial and operational matters, internal control evaluations, and audit opinions for the year 2022. It includes detailed supervisory opinions on the company's financial statements and internal controls, as well as the audit report from the accounting firm. The content is a comprehensive report on the supervisory board's work and oversight for the full fiscal year 2022, which aligns with the characteristics of an Audit Report / Information filing rather than a full Annual Report or other categories. The document length is under 5,000 characters but contains substantive supervisory and audit information, not merely an announcement or certification. Therefore, the best fitting category is Audit Report / Information (AR). FY 2022
2023-03-16 Chinese
2022年独立董事述职报告（高海军）
Board/Management Information Classification · 95% confidence The document is a detailed annual report by an independent director of Shenzhen Xinlong Health Industry Development Co., Ltd. It outlines the director's activities, attendance at board and shareholder meetings, opinions on various company matters, participation in audit committee work, and efforts to protect investor rights during the 2022 fiscal year. The content is focused on management and board-level information rather than financial results or audit opinions alone. It does not contain financial statements or earnings data, nor is it a brief announcement or certification. Therefore, the document best fits the category of Board/Management Information (MANG), as it reports on the independent director's duties, opinions, and participation in governance and management activities for the year.
2023-03-16 Chinese

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.